Literature DB >> 17329504

Failure to return for HIV test results: a pilot study of three community testing sites.

Oscar Grusky1, Kathleen Johnston Roberts, Aimee-Noelle Swanson.   

Abstract

BACKGROUND: Individuals at elevated risk of contracting HIV frequently fail to return for their test result. Because rapid HIV antibody testing is still not widely implemented, failure to return for test results under conditions of standard testing remains a problem.
METHODS: Direct field observation and semistructured interviews with clients (N = 16) and test counselors (N = 16) of 3 community HIV testing sites were conducted.
RESULTS: Clients faced 5 barriers to receiving their result: (1) fear, (2) busyness, (3) apathy,(4) inebriation at the time of testing, and (5) testing "on a whim." Motivators that encouraged clients to receive their results were (1) positive counselor/client interactions, (2) client-friendly policies regarding picking up the test result, (3) clients' psychological "need to know," (4) incentives for picking up the result, and (5) established protocols for contacting clients who fail to return.
CONCLUSION: Findings highlight the need for interventions to improve the return rate for HIV results.

Mesh:

Year:  2007        PMID: 17329504     DOI: 10.1177/1545109706297530

Source DB:  PubMed          Journal:  J Int Assoc Physicians AIDS Care (Chic)        ISSN: 1545-1097


  9 in total

1.  Case report: HIV test misdiagnosis.

Authors:  Nyirenda Mulinda; Kumwenda Johnstone; Kumwenda Newton
Journal:  Malawi Med J       Date:  2011-12       Impact factor: 0.875

2.  Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals.

Authors:  Brian Louie; Ernest Wong; Jeffrey D Klausner; Sally Liska; Frederick Hecht; Terri Dowling; Martha Obeso; Susan S Phillips; Mark W Pandori
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

3.  Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.

Authors:  Jemima A Frimpong; Thomas D'Aunno; Stéphane Helleringer; Lisa R Metsch
Journal:  J Subst Abuse Treat       Date:  2015-12-28

4.  Supporting Adolescents to Adhere (SATA): Lessons learned from an intervention to achieve medication adherence targets among youth living with HIV in Uganda.

Authors:  Sarah MacCarthy; Alexandra Mendoza-Graf; Haijing Huang; Barbara Mukasa; Sebastian Linnemayr
Journal:  Child Youth Serv Rev       Date:  2019-04-06

5.  Audit of HIV counselling and testing services among primary healthcare facilities in Cameroon: a protocol for a multicentre national cross-sectional study.

Authors:  Frank-Leonel Tianyi; Joel Noutakdie Tochie; Valirie Ndip Agbor; Benjamin Momo Kadia
Journal:  BMJ Open       Date:  2018-03-01       Impact factor: 2.692

6.  Towards an ultra-rapid smartphone- connected test for infectious diseases.

Authors:  Valérian Turbé; Eleanor R Gray; Victoria E Lawson; Eleni Nastouli; Jennifer C Brookes; Robin A Weiss; Deenan Pillay; Vincent C Emery; C Theo Verrips; Hiromi Yatsuda; Dale Athey; Rachel A McKendry
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

7.  Why individuals fail to collect HIV-test results: an exploratory study at a testing and counseling center in Mexico City.

Authors:  Ester Gutiérrez; Maria Candela Iglesias; Francisco Javier Quezada-Juarez; Evelyn Rodríguez-Estrada; Gustavo Reyes-Terán; Nancy Patricia Caballero-Suárez
Journal:  Rev Panam Salud Publica       Date:  2018-03-16

8.  Utilization of Rapid Diagnostic Testing in sub-Saharan Africa: Challenges and Effects on HIV Prevention.

Authors:  Elizabeth Armstrong-Mensah; Ato Kwamena Tetteh; Seung Choi
Journal:  Int J MCH AIDS       Date:  2020-12-30

9.  On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.

Authors:  Jemima A Frimpong; Thomas D'Aunno; David C Perlman; Shiela M Strauss; Alissa Mallow; Diana Hernandez; Bruce R Schackman; Daniel J Feaster; Lisa R Metsch
Journal:  Trials       Date:  2016-03-03       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.